Evidence map›Paper›PMID 1778766›Full record

ArticleJapanese journal of cancer research : Gann1991

Aberrant elevation of tyrosine-specific phosphorylation in human gastric cancer cells.

E Takeshima, M Hamaguchi, T Watanabe, S Akiyama, M Kataoka, Y Ohnishi, H Y Xiao, Y Nagai, H Takagi

Open access · bronzeAbstract read
In one paragraph

Article in Japanese journal of cancer research : Gann, 1991. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.3field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Targeted therapies in gastric cancer and future perspectives.World journal of gastroenterology · 2016
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Immunohistochemical evaluation of alpha-catenin expression in human gastric cancer.Virchows Archiv : an international journal of pathology · 1994
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

E TakeshimaDepartment of Surgery II, Nagoya University School of Medicine.
M Hamaguchi
T Watanabe
S Akiyama
M Kataoka
Y Ohnishi
H Y Xiao
Y Nagai
H Takagi
Nagoya University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Phosphotyrosine-containing proteins in various human cancer cell lines were studied by immunoblotting with anti-phosphotyrosine antibody. Of 29 cell lines derived from oral epidermoid cancer, esophageal cancer, gastric cancer, colon cancer, pancreatic cancer, hepatocellular carcinoma and malignant melanoma, 3 of the 6 gastric cancer cells showed aberrant elevation of tyrosine-specific phosphorylation. On the other hand, both esophageal cancer cells and colon cancer cells, which were reported to have amplified epidermal growth factor receptor and activated p60v-src kinase, respectively, showed no apparent elevation of tyrosine-specific phosphorylation, and their profiles of phosphorylation were similar to that of normal human fibroblasts. Two gastric cancer cells, NUGC-4 and MKN-45, showed similar profiles of phosphorylation but their responses to growth factors differed from each other. Tyrosine phosphorylation in NUGC-4 was strongly activated by treatment with epidermal growth factor and quickly reduced by the acid treatment which is effective in removing growth factors from cellular surface receptors. On the contrary, phosphorylation in MKN-45 did not respond to either growth factor or acid treatment. These results suggest that NUGC-4 and MKN-45 have tyrosine kinases which are activated by different mechanisms but share similar substrates.

Indexed as

ErbB ReceptorsFluorescent Antibody TechniqueGrowth SubstancesHumansNeoplasm ProteinsPhosphoproteinsPhosphorylationProtein-Tyrosine KinasesStimulation, ChemicalStomach NeoplasmsTumor Cells, CulturedTyrosineErbB ReceptorsGrowth SubstancesNeoplasm ProteinsPhosphoproteinsProtein-Tyrosine KinasesTyrosine

Identifiers

PMID1778766
PMCPMC5918361
OpenAlexW1988101540

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.